Ross M Maltz

Contact Information

Call us at: (614) 722-3450

Fax us at: (614) 722-3454

Email Ross M. Maltz, MD

PediatricsGastroenterology & Hepatology & Nutrition700 Children’s DrColumbus, OH 43205 (map)

Learn more about Ross M. Maltz

Biography

Ross M. Maltz MD, is an attending pediatric gastroenterologist at Nationwide Children’s Hospital, part of the Inflammatory Bowel Disease center, and an assistant professor of clinical pediatrics at The Ohio State University College of Medicine. Dr. Maltz’s clinical interest involves all aspects of pediatric gastroenterology with a special interest in inflammatory bowel disease in particular very early onset inflammatory bowel disease.  As a principal investigator in the Center for Microbial Pathogenesis at The Research Institute at Nationwide Children’s Hospital, he conducts basic science research studying the impact of stressor exposure has on inflammation and the microbiome. Dr. Maltz received the prestigious 2016 NASPGHAN Foundation Fellow to Faculty Transition Award in Inflammatory Bowel Disease to support his work on the effect of stressor exposure in inflammatory bowel disease.

Academic and Clinical Areas

Inflammatory Bowel Disease

Physician Team

Gastroenterology, Hepatology & Nutrition

Physician Team

Primary Department

Pediatrics

Primary Section

Gastroenterology & Hepatology & Nutrition

Research

View My Publications Publications

                  Megan McNicol M, Donegan A, Hawa K, Boutzoukas AE, Drobnic B, Oates M, Orraca-Tetteh M, Michel HK, Maltz RM, Dotson JL, Buckingham D, Boyle B, Ardura MI. Improving Hepatitis B Vaccination Rates among At-risk Children and Adolescents with Inflammatory Bowel Disease. Pediatr Qual Saf. 2022 Jul-Aug; 7: e570.

                


                  Kerur B, Fiedler K, Stahl M, Hyams J, Stephens M, Lu Y, Pfefferkorn M, Alkhouri R, Strople J, Kelsen J, Siebold L, Goyal A, Rosh JR, LeLeiko N, Van Limbergen J, Guerrerio AL, Maltz RM, Karam L, Crowley E, Griffiths AM, Heyman MB, Deneau M, Benkov K, Noe J, Moulton D, Pappa H, Galanko J, Snapper S, Muise AM, Kappelman MD, Benchimol EI. Utilization of anti-tumor necrosis factor biologics in Very Early Onset Inflammatory Bowel Disease (VEOIBD): a multicenter retrospective cohort study from North America. J Pediatr Gastroenterol Nutr. 2022 May 27;  

                


                  Davidson N, Rutsky J, Bricker JB, Smith J, Maltz RM, Dotson JL, Michel HK, Boyle B. 6 and 12-Month Outcomes After 90:10 Enteral Nutrition Induction Therapy in Pediatric Crohn's Disease. J Pediatr Gastroenterol Nutr. 2022 May 27;  

                


                  Maltz RM, Marte-Ortiz P, Rajasekera TA, Loman BR, Gur TL, Bailey MT. Stressor-Induced Increases in Circulating, but Not Colonic, Cytokines Are Related to Anxiety-like Behavior and Hippocampal Inflammation in a Murine Colitis Model. Int J Mol Sci. 2022 Feb 11; 23: 

                


                  Hill EB, Chen L, Bailey MT, Singh Khalsa A, Maltz R, Kelleher K, Spees CK, Zhu J, Loman BR. Facilitating a high-quality dietary pattern induces shared microbial responses linking diet quality, blood pressure, and microbial sterol metabolism in caregiver-child dyads. Gut Microbes. 2022 Jan-Dec; 14: 2150502.

                


                  Salman SS, Williams KC, Marte-Ortiz P, Rumpf W, Mashburn-Warren L, Lauber CL, Bailey MT, Maltz RM. Polyethylene Glycol 3350 Changes Stool Consistency and the Microbiome but not Behavior of CD1 Mice. J Pediatr Gastroenterol Nutr. 2021 Oct 1; 73: 499-506.

                


                  Michel HK, Boyle B, David J, Donegan A, Drobnic B, Kren C, Maltz RM, McKillop HN, McNicol M, Oates M, Dotson JL. The Pediatric Inflammatory Bowel Disease Medical Home: A Proposed Model. Inflamm Bowel Dis. 2021 Sep 25;  

                


                  Morris GA, McNicol M, Boyle B, Donegan A, Dotson J, Michel HK, Maltz RM. Increasing Biosimilar Utilization at a Pediatric Inflammatory Bowel Disease Center and Associated Cost Savings: Show Me the Money. Inflamm Bowel Dis. 2021 May 25;  

                


                  Pearlstein H, Bricker J, Michel HK, Afzali A, Donegan AM, Maltz RM, Boyle BM, Dotson JL. Predicting Suboptimal Transitions in Adolescents With Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr. 2021 Apr 1; 72: 563-568.

                


                  Kerur B, Benchimol EI, Fiedler K, Stahl M, Hyams J, Stephens M, Lu Y, Pfefferkorn M, Alkhouri R, Strople J, Kelsen J, Siebold L, Goyal A, Rosh JR, LeLeiko N, Van Limbergen J, Guerrerio AL, Maltz R, Karam L, Crowley E, Griffiths A, Heyman MB, Deneau M, Benkov K, Noe J, Mouton D, Pappa H, Galanko JA, Snapper S, Muise AM, Kappelman MD. Natural History of? Very Early Onset Inflammatory Bowel Disease in North America: A Retrospective Cohort Study. Inflamm Bowel Dis. 2020 May 9;  

                


                  Lee R, Maltz RM, Crandall WV, Plogsted SW, Shaikhkhalil AK, Bowden SA, Mezoff EA. Single High-dose Vitamin D3 Supplementation in Pediatric Patients With Inflammatory Bowel Disease and Hypovitaminosis D. J Pediatr Gastroenterol Nutr. 2020 Apr; 70: e77-e80.

                


                  Mackner LM, Hatzakis E, Allen JM, Davies RH, Kim SC, Maltz RM, Bailey MT. Fecal microbiota and metabolites are distinct in a pilot study of pediatric Crohn's disease patients with higher levels of perceived stress. Psychoneuroendocrinology. 2020 Jan; 111: 104469.

                


                  Guido AJ, Crandall W, Homan E, Dotson J, Maltz RM, Donegan A, Drobnic B, Oates M, Boyle B. Improving Post-induction Antitumor Necrosis Factor Therapeutic Drug Monitoring in Pediatric Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr. 2020 Jan; 70: 48-54.

                


                  Gupta SR, Crandall WV, Donegan A, Johnson M, Drobnic B, Oates M, Boyle B, Maltz RM, Dotson JL. A Quality Improvement Approach to External Infliximab Infusions in Pediatric Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr. 2019 Nov; 69: 544-550.

                


                  Maltz RM, Keirsey J, Kim SC, Mackos AR, Gharaibeh RZ, Moore CC, Xu J, Somogyi A, Bailey MT. Social Stress Affects Colonic Inflammation, the Gut Microbiome, and Short-chain Fatty Acid Levels and Receptors. J Pediatr Gastroenterol Nutr. 2019 Apr; 68: 533-540.

                


                  Serpico MR, Maltz R, Crandall W, Bricker J, Dotson JL, Kim SC, Boyle B. Thiopurine Optimization Through Combination With Allopurinol in Children With Inflammatory Bowel Diseases. J Pediatr Gastroenterol Nutr. 2018 Sep; 67: 341-345.

                


                  Shaikhkhalil AK, Boyle B, Smith J, Dotson JL, Donegan A, Kim SC, Maltz RM, Crandall W. Using Quality Improvement to Increase Utilization of Enteral Therapy in Pediatric Crohn Disease: Results and Outcomes. J Pediatr Gastroenterol Nutr. 2018 Jun; 66: 909-914.

                


                  Sridhar S, Maltz RM, Boyle B, Kim SC. Dermatological Manifestations in Pediatric Patients with Inflammatory Bowel Diseases on Anti-TNF Therapy. Inflamm Bowel Dis. 2018 Apr 27;  

                


                  Maltz RM, Keirsey J, Kim SC, Mackos AR, Gharaibeh RZ, Moore CC, Xu J, Bakthavatchalu V, Somogyi A, Bailey MT. Prolonged restraint stressor exposure in outbred CD-1 mice impacts microbiota, colonic inflammation, and short chain fatty acids. PLoS One. 2018; 13: e0196961.

View More Publications

Education

Date of Appointment at Nationwide Children’s Hospital: 09/26/2014

Board Certifications

Pediatric Gastroenterology

Fellowship

Nationwide Children’s Hospital

Date Completed: 06/30/2016

Residency

Winthrop University Hospital

Date Completed: 06/30/2013

Medical School

St. Georges University

Date Completed: 04/09/2010

Contact Information

Pediatrics

Call us at: (614) 722-3450

Fax us at: (614) 722-3454

Email Ross M Maltz

                    Gastroenterology & Hepatology & Nutrition700 Children's DrColumbus, OH 43205 (map)

Contact Information

Call us at: (614) 722-3450

Fax us at: (614) 722-3454

Email Ross M. Maltz, MD

PediatricsGastroenterology & Hepatology & Nutrition700 Children’s DrColumbus, OH 43205 (map)

Learn more about Ross M. Maltz

Biography

Ross M. Maltz MD, is an attending pediatric gastroenterologist at Nationwide Children’s Hospital, part of the Inflammatory Bowel Disease center, and an assistant professor of clinical pediatrics at The Ohio State University College of Medicine. Dr. Maltz’s clinical interest involves all aspects of pediatric gastroenterology with a special interest in inflammatory bowel disease in particular very early onset inflammatory bowel disease.  As a principal investigator in the Center for Microbial Pathogenesis at The Research Institute at Nationwide Children’s Hospital, he conducts basic science research studying the impact of stressor exposure has on inflammation and the microbiome. Dr. Maltz received the prestigious 2016 NASPGHAN Foundation Fellow to Faculty Transition Award in Inflammatory Bowel Disease to support his work on the effect of stressor exposure in inflammatory bowel disease.

Academic and Clinical Areas

Inflammatory Bowel Disease

Physician Team

Gastroenterology, Hepatology & Nutrition

Physician Team

Primary Department

Pediatrics

Primary Section

Gastroenterology & Hepatology & Nutrition

Research

View My Publications Publications

                  Megan McNicol M, Donegan A, Hawa K, Boutzoukas AE, Drobnic B, Oates M, Orraca-Tetteh M, Michel HK, Maltz RM, Dotson JL, Buckingham D, Boyle B, Ardura MI. Improving Hepatitis B Vaccination Rates among At-risk Children and Adolescents with Inflammatory Bowel Disease. Pediatr Qual Saf. 2022 Jul-Aug; 7: e570.

                


                  Kerur B, Fiedler K, Stahl M, Hyams J, Stephens M, Lu Y, Pfefferkorn M, Alkhouri R, Strople J, Kelsen J, Siebold L, Goyal A, Rosh JR, LeLeiko N, Van Limbergen J, Guerrerio AL, Maltz RM, Karam L, Crowley E, Griffiths AM, Heyman MB, Deneau M, Benkov K, Noe J, Moulton D, Pappa H, Galanko J, Snapper S, Muise AM, Kappelman MD, Benchimol EI. Utilization of anti-tumor necrosis factor biologics in Very Early Onset Inflammatory Bowel Disease (VEOIBD): a multicenter retrospective cohort study from North America. J Pediatr Gastroenterol Nutr. 2022 May 27;  

                


                  Davidson N, Rutsky J, Bricker JB, Smith J, Maltz RM, Dotson JL, Michel HK, Boyle B. 6 and 12-Month Outcomes After 90:10 Enteral Nutrition Induction Therapy in Pediatric Crohn's Disease. J Pediatr Gastroenterol Nutr. 2022 May 27;  

                


                  Maltz RM, Marte-Ortiz P, Rajasekera TA, Loman BR, Gur TL, Bailey MT. Stressor-Induced Increases in Circulating, but Not Colonic, Cytokines Are Related to Anxiety-like Behavior and Hippocampal Inflammation in a Murine Colitis Model. Int J Mol Sci. 2022 Feb 11; 23: 

                


                  Hill EB, Chen L, Bailey MT, Singh Khalsa A, Maltz R, Kelleher K, Spees CK, Zhu J, Loman BR. Facilitating a high-quality dietary pattern induces shared microbial responses linking diet quality, blood pressure, and microbial sterol metabolism in caregiver-child dyads. Gut Microbes. 2022 Jan-Dec; 14: 2150502.

                


                  Salman SS, Williams KC, Marte-Ortiz P, Rumpf W, Mashburn-Warren L, Lauber CL, Bailey MT, Maltz RM. Polyethylene Glycol 3350 Changes Stool Consistency and the Microbiome but not Behavior of CD1 Mice. J Pediatr Gastroenterol Nutr. 2021 Oct 1; 73: 499-506.

                


                  Michel HK, Boyle B, David J, Donegan A, Drobnic B, Kren C, Maltz RM, McKillop HN, McNicol M, Oates M, Dotson JL. The Pediatric Inflammatory Bowel Disease Medical Home: A Proposed Model. Inflamm Bowel Dis. 2021 Sep 25;  

                


                  Morris GA, McNicol M, Boyle B, Donegan A, Dotson J, Michel HK, Maltz RM. Increasing Biosimilar Utilization at a Pediatric Inflammatory Bowel Disease Center and Associated Cost Savings: Show Me the Money. Inflamm Bowel Dis. 2021 May 25;  

                


                  Pearlstein H, Bricker J, Michel HK, Afzali A, Donegan AM, Maltz RM, Boyle BM, Dotson JL. Predicting Suboptimal Transitions in Adolescents With Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr. 2021 Apr 1; 72: 563-568.

                


                  Kerur B, Benchimol EI, Fiedler K, Stahl M, Hyams J, Stephens M, Lu Y, Pfefferkorn M, Alkhouri R, Strople J, Kelsen J, Siebold L, Goyal A, Rosh JR, LeLeiko N, Van Limbergen J, Guerrerio AL, Maltz R, Karam L, Crowley E, Griffiths A, Heyman MB, Deneau M, Benkov K, Noe J, Mouton D, Pappa H, Galanko JA, Snapper S, Muise AM, Kappelman MD. Natural History of? Very Early Onset Inflammatory Bowel Disease in North America: A Retrospective Cohort Study. Inflamm Bowel Dis. 2020 May 9;  

                


                  Lee R, Maltz RM, Crandall WV, Plogsted SW, Shaikhkhalil AK, Bowden SA, Mezoff EA. Single High-dose Vitamin D3 Supplementation in Pediatric Patients With Inflammatory Bowel Disease and Hypovitaminosis D. J Pediatr Gastroenterol Nutr. 2020 Apr; 70: e77-e80.

                


                  Mackner LM, Hatzakis E, Allen JM, Davies RH, Kim SC, Maltz RM, Bailey MT. Fecal microbiota and metabolites are distinct in a pilot study of pediatric Crohn's disease patients with higher levels of perceived stress. Psychoneuroendocrinology. 2020 Jan; 111: 104469.

                


                  Guido AJ, Crandall W, Homan E, Dotson J, Maltz RM, Donegan A, Drobnic B, Oates M, Boyle B. Improving Post-induction Antitumor Necrosis Factor Therapeutic Drug Monitoring in Pediatric Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr. 2020 Jan; 70: 48-54.

                


                  Gupta SR, Crandall WV, Donegan A, Johnson M, Drobnic B, Oates M, Boyle B, Maltz RM, Dotson JL. A Quality Improvement Approach to External Infliximab Infusions in Pediatric Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr. 2019 Nov; 69: 544-550.

                


                  Maltz RM, Keirsey J, Kim SC, Mackos AR, Gharaibeh RZ, Moore CC, Xu J, Somogyi A, Bailey MT. Social Stress Affects Colonic Inflammation, the Gut Microbiome, and Short-chain Fatty Acid Levels and Receptors. J Pediatr Gastroenterol Nutr. 2019 Apr; 68: 533-540.

                


                  Serpico MR, Maltz R, Crandall W, Bricker J, Dotson JL, Kim SC, Boyle B. Thiopurine Optimization Through Combination With Allopurinol in Children With Inflammatory Bowel Diseases. J Pediatr Gastroenterol Nutr. 2018 Sep; 67: 341-345.

                


                  Shaikhkhalil AK, Boyle B, Smith J, Dotson JL, Donegan A, Kim SC, Maltz RM, Crandall W. Using Quality Improvement to Increase Utilization of Enteral Therapy in Pediatric Crohn Disease: Results and Outcomes. J Pediatr Gastroenterol Nutr. 2018 Jun; 66: 909-914.

                


                  Sridhar S, Maltz RM, Boyle B, Kim SC. Dermatological Manifestations in Pediatric Patients with Inflammatory Bowel Diseases on Anti-TNF Therapy. Inflamm Bowel Dis. 2018 Apr 27;  

                


                  Maltz RM, Keirsey J, Kim SC, Mackos AR, Gharaibeh RZ, Moore CC, Xu J, Bakthavatchalu V, Somogyi A, Bailey MT. Prolonged restraint stressor exposure in outbred CD-1 mice impacts microbiota, colonic inflammation, and short chain fatty acids. PLoS One. 2018; 13: e0196961.

View More Publications

Education

Date of Appointment at Nationwide Children’s Hospital: 09/26/2014

Board Certifications

Pediatric Gastroenterology

Fellowship

Nationwide Children’s Hospital

Date Completed: 06/30/2016

Residency

Winthrop University Hospital

Date Completed: 06/30/2013

Medical School

St. Georges University

Date Completed: 04/09/2010

Contact Information

Pediatrics

Call us at: (614) 722-3450

Fax us at: (614) 722-3454

Email Ross M Maltz

                    Gastroenterology & Hepatology & Nutrition700 Children's DrColumbus, OH 43205 (map)

Contact Information

Call us at: (614) 722-3450

Fax us at: (614) 722-3454

Email Ross M. Maltz, MD

PediatricsGastroenterology & Hepatology & Nutrition700 Children’s DrColumbus, OH 43205 (map)

Learn more about Ross M. Maltz

Contact Information

• Call us at:
• (614) 722-3450
• Fax us at:
• (614) 722-3454
• Email Ross M. Maltz, MD
• PediatricsGastroenterology & Hepatology & Nutrition700 Children’s DrColumbus, OH 43205 (map)

Learn more about Ross M. Maltz

Biography

Ross M. Maltz MD, is an attending pediatric gastroenterologist at Nationwide Children’s Hospital, part of the Inflammatory Bowel Disease center, and an assistant professor of clinical pediatrics at The Ohio State University College of Medicine. Dr. Maltz’s clinical interest involves all aspects of pediatric gastroenterology with a special interest in inflammatory bowel disease in particular very early onset inflammatory bowel disease.  As a principal investigator in the Center for Microbial Pathogenesis at The Research Institute at Nationwide Children’s Hospital, he conducts basic science research studying the impact of stressor exposure has on inflammation and the microbiome. Dr. Maltz received the prestigious 2016 NASPGHAN Foundation Fellow to Faculty Transition Award in Inflammatory Bowel Disease to support his work on the effect of stressor exposure in inflammatory bowel disease.

Biography

Ross M. Maltz MD, is an attending pediatric gastroenterologist at Nationwide Children’s Hospital, part of the Inflammatory Bowel Disease center, and an assistant professor of clinical pediatrics at The Ohio State University College of Medicine. Dr. Maltz’s clinical interest involves all aspects of pediatric gastroenterology with a special interest in inflammatory bowel disease in particular very early onset inflammatory bowel disease.  As a principal investigator in the Center for Microbial Pathogenesis at The Research Institute at Nationwide Children’s Hospital, he conducts basic science research studying the impact of stressor exposure has on inflammation and the microbiome. Dr. Maltz received the prestigious 2016 NASPGHAN Foundation Fellow to Faculty Transition Award in Inflammatory Bowel Disease to support his work on the effect of stressor exposure in inflammatory bowel disease.

Biography

Ross M. Maltz MD, is an attending pediatric gastroenterologist at Nationwide Children’s Hospital, part of the Inflammatory Bowel Disease center, and an assistant professor of clinical pediatrics at The Ohio State University College of Medicine. Dr. Maltz’s clinical interest involves all aspects of pediatric gastroenterology with a special interest in inflammatory bowel disease in particular very early onset inflammatory bowel disease.  As a principal investigator in the Center for Microbial Pathogenesis at The Research Institute at Nationwide Children’s Hospital, he conducts basic science research studying the impact of stressor exposure has on inflammation and the microbiome. Dr. Maltz received the prestigious 2016 NASPGHAN Foundation Fellow to Faculty Transition Award in Inflammatory Bowel Disease to support his work on the effect of stressor exposure in inflammatory bowel disease.

Ross M. Maltz MD, is an attending pediatric gastroenterologist at Nationwide Children’s Hospital, part of the Inflammatory Bowel Disease center, and an assistant professor of clinical pediatrics at The Ohio State University College of Medicine. Dr. Maltz’s clinical interest involves all aspects of pediatric gastroenterology with a special interest in inflammatory bowel disease in particular very early onset inflammatory bowel disease.  As a principal investigator in the Center for Microbial Pathogenesis at The Research Institute at Nationwide Children’s Hospital, he conducts basic science research studying the impact of stressor exposure has on inflammation and the microbiome. Dr. Maltz received the prestigious 2016 NASPGHAN Foundation Fellow to Faculty Transition Award in Inflammatory Bowel Disease to support his work on the effect of stressor exposure in inflammatory bowel disease.

Ross M. Maltz MD, is an attending pediatric gastroenterologist at Nationwide Children’s Hospital, part of the Inflammatory Bowel Disease center, and an assistant professor of clinical pediatrics at The Ohio State University College of Medicine. Dr. Maltz’s clinical interest involves all aspects of pediatric gastroenterology with a special interest in inflammatory bowel disease in particular very early onset inflammatory bowel disease.  As a principal investigator in the Center for Microbial Pathogenesis at The Research Institute at Nationwide Children’s Hospital, he conducts basic science research studying the impact of stressor exposure has on inflammation and the microbiome. Dr. Maltz received the prestigious 2016 NASPGHAN Foundation Fellow to Faculty Transition Award in Inflammatory Bowel Disease to support his work on the effect of stressor exposure in inflammatory bowel disease.

Academic and Clinical Areas

Inflammatory Bowel Disease

Physician Team

Gastroenterology, Hepatology & Nutrition

Physician Team

Primary Department

Pediatrics

Primary Section

Gastroenterology & Hepatology & Nutrition

Academic and Clinical Areas

Inflammatory Bowel Disease

Physician Team

Gastroenterology, Hepatology & Nutrition

Physician Team

Primary Department

Pediatrics

Primary Section

Gastroenterology & Hepatology & Nutrition

Academic and Clinical Areas

Inflammatory Bowel Disease

Physician Team

Gastroenterology, Hepatology & Nutrition

Physician Team

Primary Department

Pediatrics

Primary Section

Gastroenterology & Hepatology & Nutrition

Inflammatory Bowel Disease

Physician Team

Gastroenterology, Hepatology & Nutrition

Physician Team

Primary Department

Pediatrics

Primary Section

Gastroenterology & Hepatology & Nutrition

• Inflammatory Bowel Disease
• Physician Team
• Gastroenterology, Hepatology & Nutrition
• Physician Team
• Primary Department
• Pediatrics
• Primary Section
• Gastroenterology & Hepatology & Nutrition

Research

View My Publications Publications

                  Megan McNicol M, Donegan A, Hawa K, Boutzoukas AE, Drobnic B, Oates M, Orraca-Tetteh M, Michel HK, Maltz RM, Dotson JL, Buckingham D, Boyle B, Ardura MI. Improving Hepatitis B Vaccination Rates among At-risk Children and Adolescents with Inflammatory Bowel Disease. Pediatr Qual Saf. 2022 Jul-Aug; 7: e570.

                


                  Kerur B, Fiedler K, Stahl M, Hyams J, Stephens M, Lu Y, Pfefferkorn M, Alkhouri R, Strople J, Kelsen J, Siebold L, Goyal A, Rosh JR, LeLeiko N, Van Limbergen J, Guerrerio AL, Maltz RM, Karam L, Crowley E, Griffiths AM, Heyman MB, Deneau M, Benkov K, Noe J, Moulton D, Pappa H, Galanko J, Snapper S, Muise AM, Kappelman MD, Benchimol EI. Utilization of anti-tumor necrosis factor biologics in Very Early Onset Inflammatory Bowel Disease (VEOIBD): a multicenter retrospective cohort study from North America. J Pediatr Gastroenterol Nutr. 2022 May 27;  

                


                  Davidson N, Rutsky J, Bricker JB, Smith J, Maltz RM, Dotson JL, Michel HK, Boyle B. 6 and 12-Month Outcomes After 90:10 Enteral Nutrition Induction Therapy in Pediatric Crohn's Disease. J Pediatr Gastroenterol Nutr. 2022 May 27;  

                


                  Maltz RM, Marte-Ortiz P, Rajasekera TA, Loman BR, Gur TL, Bailey MT. Stressor-Induced Increases in Circulating, but Not Colonic, Cytokines Are Related to Anxiety-like Behavior and Hippocampal Inflammation in a Murine Colitis Model. Int J Mol Sci. 2022 Feb 11; 23: 

                


                  Hill EB, Chen L, Bailey MT, Singh Khalsa A, Maltz R, Kelleher K, Spees CK, Zhu J, Loman BR. Facilitating a high-quality dietary pattern induces shared microbial responses linking diet quality, blood pressure, and microbial sterol metabolism in caregiver-child dyads. Gut Microbes. 2022 Jan-Dec; 14: 2150502.

                


                  Salman SS, Williams KC, Marte-Ortiz P, Rumpf W, Mashburn-Warren L, Lauber CL, Bailey MT, Maltz RM. Polyethylene Glycol 3350 Changes Stool Consistency and the Microbiome but not Behavior of CD1 Mice. J Pediatr Gastroenterol Nutr. 2021 Oct 1; 73: 499-506.

                


                  Michel HK, Boyle B, David J, Donegan A, Drobnic B, Kren C, Maltz RM, McKillop HN, McNicol M, Oates M, Dotson JL. The Pediatric Inflammatory Bowel Disease Medical Home: A Proposed Model. Inflamm Bowel Dis. 2021 Sep 25;  

                


                  Morris GA, McNicol M, Boyle B, Donegan A, Dotson J, Michel HK, Maltz RM. Increasing Biosimilar Utilization at a Pediatric Inflammatory Bowel Disease Center and Associated Cost Savings: Show Me the Money. Inflamm Bowel Dis. 2021 May 25;  

                


                  Pearlstein H, Bricker J, Michel HK, Afzali A, Donegan AM, Maltz RM, Boyle BM, Dotson JL. Predicting Suboptimal Transitions in Adolescents With Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr. 2021 Apr 1; 72: 563-568.

                


                  Kerur B, Benchimol EI, Fiedler K, Stahl M, Hyams J, Stephens M, Lu Y, Pfefferkorn M, Alkhouri R, Strople J, Kelsen J, Siebold L, Goyal A, Rosh JR, LeLeiko N, Van Limbergen J, Guerrerio AL, Maltz R, Karam L, Crowley E, Griffiths A, Heyman MB, Deneau M, Benkov K, Noe J, Mouton D, Pappa H, Galanko JA, Snapper S, Muise AM, Kappelman MD. Natural History of? Very Early Onset Inflammatory Bowel Disease in North America: A Retrospective Cohort Study. Inflamm Bowel Dis. 2020 May 9;  

                


                  Lee R, Maltz RM, Crandall WV, Plogsted SW, Shaikhkhalil AK, Bowden SA, Mezoff EA. Single High-dose Vitamin D3 Supplementation in Pediatric Patients With Inflammatory Bowel Disease and Hypovitaminosis D. J Pediatr Gastroenterol Nutr. 2020 Apr; 70: e77-e80.

                


                  Mackner LM, Hatzakis E, Allen JM, Davies RH, Kim SC, Maltz RM, Bailey MT. Fecal microbiota and metabolites are distinct in a pilot study of pediatric Crohn's disease patients with higher levels of perceived stress. Psychoneuroendocrinology. 2020 Jan; 111: 104469.

                


                  Guido AJ, Crandall W, Homan E, Dotson J, Maltz RM, Donegan A, Drobnic B, Oates M, Boyle B. Improving Post-induction Antitumor Necrosis Factor Therapeutic Drug Monitoring in Pediatric Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr. 2020 Jan; 70: 48-54.

                


                  Gupta SR, Crandall WV, Donegan A, Johnson M, Drobnic B, Oates M, Boyle B, Maltz RM, Dotson JL. A Quality Improvement Approach to External Infliximab Infusions in Pediatric Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr. 2019 Nov; 69: 544-550.

                


                  Maltz RM, Keirsey J, Kim SC, Mackos AR, Gharaibeh RZ, Moore CC, Xu J, Somogyi A, Bailey MT. Social Stress Affects Colonic Inflammation, the Gut Microbiome, and Short-chain Fatty Acid Levels and Receptors. J Pediatr Gastroenterol Nutr. 2019 Apr; 68: 533-540.

                


                  Serpico MR, Maltz R, Crandall W, Bricker J, Dotson JL, Kim SC, Boyle B. Thiopurine Optimization Through Combination With Allopurinol in Children With Inflammatory Bowel Diseases. J Pediatr Gastroenterol Nutr. 2018 Sep; 67: 341-345.

                


                  Shaikhkhalil AK, Boyle B, Smith J, Dotson JL, Donegan A, Kim SC, Maltz RM, Crandall W. Using Quality Improvement to Increase Utilization of Enteral Therapy in Pediatric Crohn Disease: Results and Outcomes. J Pediatr Gastroenterol Nutr. 2018 Jun; 66: 909-914.

                


                  Sridhar S, Maltz RM, Boyle B, Kim SC. Dermatological Manifestations in Pediatric Patients with Inflammatory Bowel Diseases on Anti-TNF Therapy. Inflamm Bowel Dis. 2018 Apr 27;  

                


                  Maltz RM, Keirsey J, Kim SC, Mackos AR, Gharaibeh RZ, Moore CC, Xu J, Bakthavatchalu V, Somogyi A, Bailey MT. Prolonged restraint stressor exposure in outbred CD-1 mice impacts microbiota, colonic inflammation, and short chain fatty acids. PLoS One. 2018; 13: e0196961.

View More Publications

Research

View My Publications Publications

                  Megan McNicol M, Donegan A, Hawa K, Boutzoukas AE, Drobnic B, Oates M, Orraca-Tetteh M, Michel HK, Maltz RM, Dotson JL, Buckingham D, Boyle B, Ardura MI. Improving Hepatitis B Vaccination Rates among At-risk Children and Adolescents with Inflammatory Bowel Disease. Pediatr Qual Saf. 2022 Jul-Aug; 7: e570.

                


                  Kerur B, Fiedler K, Stahl M, Hyams J, Stephens M, Lu Y, Pfefferkorn M, Alkhouri R, Strople J, Kelsen J, Siebold L, Goyal A, Rosh JR, LeLeiko N, Van Limbergen J, Guerrerio AL, Maltz RM, Karam L, Crowley E, Griffiths AM, Heyman MB, Deneau M, Benkov K, Noe J, Moulton D, Pappa H, Galanko J, Snapper S, Muise AM, Kappelman MD, Benchimol EI. Utilization of anti-tumor necrosis factor biologics in Very Early Onset Inflammatory Bowel Disease (VEOIBD): a multicenter retrospective cohort study from North America. J Pediatr Gastroenterol Nutr. 2022 May 27;  

                


                  Davidson N, Rutsky J, Bricker JB, Smith J, Maltz RM, Dotson JL, Michel HK, Boyle B. 6 and 12-Month Outcomes After 90:10 Enteral Nutrition Induction Therapy in Pediatric Crohn's Disease. J Pediatr Gastroenterol Nutr. 2022 May 27;  

                


                  Maltz RM, Marte-Ortiz P, Rajasekera TA, Loman BR, Gur TL, Bailey MT. Stressor-Induced Increases in Circulating, but Not Colonic, Cytokines Are Related to Anxiety-like Behavior and Hippocampal Inflammation in a Murine Colitis Model. Int J Mol Sci. 2022 Feb 11; 23: 

                


                  Hill EB, Chen L, Bailey MT, Singh Khalsa A, Maltz R, Kelleher K, Spees CK, Zhu J, Loman BR. Facilitating a high-quality dietary pattern induces shared microbial responses linking diet quality, blood pressure, and microbial sterol metabolism in caregiver-child dyads. Gut Microbes. 2022 Jan-Dec; 14: 2150502.

                


                  Salman SS, Williams KC, Marte-Ortiz P, Rumpf W, Mashburn-Warren L, Lauber CL, Bailey MT, Maltz RM. Polyethylene Glycol 3350 Changes Stool Consistency and the Microbiome but not Behavior of CD1 Mice. J Pediatr Gastroenterol Nutr. 2021 Oct 1; 73: 499-506.

                


                  Michel HK, Boyle B, David J, Donegan A, Drobnic B, Kren C, Maltz RM, McKillop HN, McNicol M, Oates M, Dotson JL. The Pediatric Inflammatory Bowel Disease Medical Home: A Proposed Model. Inflamm Bowel Dis. 2021 Sep 25;  

                


                  Morris GA, McNicol M, Boyle B, Donegan A, Dotson J, Michel HK, Maltz RM. Increasing Biosimilar Utilization at a Pediatric Inflammatory Bowel Disease Center and Associated Cost Savings: Show Me the Money. Inflamm Bowel Dis. 2021 May 25;  

                


                  Pearlstein H, Bricker J, Michel HK, Afzali A, Donegan AM, Maltz RM, Boyle BM, Dotson JL. Predicting Suboptimal Transitions in Adolescents With Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr. 2021 Apr 1; 72: 563-568.

                


                  Kerur B, Benchimol EI, Fiedler K, Stahl M, Hyams J, Stephens M, Lu Y, Pfefferkorn M, Alkhouri R, Strople J, Kelsen J, Siebold L, Goyal A, Rosh JR, LeLeiko N, Van Limbergen J, Guerrerio AL, Maltz R, Karam L, Crowley E, Griffiths A, Heyman MB, Deneau M, Benkov K, Noe J, Mouton D, Pappa H, Galanko JA, Snapper S, Muise AM, Kappelman MD. Natural History of? Very Early Onset Inflammatory Bowel Disease in North America: A Retrospective Cohort Study. Inflamm Bowel Dis. 2020 May 9;  

                


                  Lee R, Maltz RM, Crandall WV, Plogsted SW, Shaikhkhalil AK, Bowden SA, Mezoff EA. Single High-dose Vitamin D3 Supplementation in Pediatric Patients With Inflammatory Bowel Disease and Hypovitaminosis D. J Pediatr Gastroenterol Nutr. 2020 Apr; 70: e77-e80.

                


                  Mackner LM, Hatzakis E, Allen JM, Davies RH, Kim SC, Maltz RM, Bailey MT. Fecal microbiota and metabolites are distinct in a pilot study of pediatric Crohn's disease patients with higher levels of perceived stress. Psychoneuroendocrinology. 2020 Jan; 111: 104469.

                


                  Guido AJ, Crandall W, Homan E, Dotson J, Maltz RM, Donegan A, Drobnic B, Oates M, Boyle B. Improving Post-induction Antitumor Necrosis Factor Therapeutic Drug Monitoring in Pediatric Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr. 2020 Jan; 70: 48-54.

                


                  Gupta SR, Crandall WV, Donegan A, Johnson M, Drobnic B, Oates M, Boyle B, Maltz RM, Dotson JL. A Quality Improvement Approach to External Infliximab Infusions in Pediatric Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr. 2019 Nov; 69: 544-550.

                


                  Maltz RM, Keirsey J, Kim SC, Mackos AR, Gharaibeh RZ, Moore CC, Xu J, Somogyi A, Bailey MT. Social Stress Affects Colonic Inflammation, the Gut Microbiome, and Short-chain Fatty Acid Levels and Receptors. J Pediatr Gastroenterol Nutr. 2019 Apr; 68: 533-540.

                


                  Serpico MR, Maltz R, Crandall W, Bricker J, Dotson JL, Kim SC, Boyle B. Thiopurine Optimization Through Combination With Allopurinol in Children With Inflammatory Bowel Diseases. J Pediatr Gastroenterol Nutr. 2018 Sep; 67: 341-345.

                


                  Shaikhkhalil AK, Boyle B, Smith J, Dotson JL, Donegan A, Kim SC, Maltz RM, Crandall W. Using Quality Improvement to Increase Utilization of Enteral Therapy in Pediatric Crohn Disease: Results and Outcomes. J Pediatr Gastroenterol Nutr. 2018 Jun; 66: 909-914.

                


                  Sridhar S, Maltz RM, Boyle B, Kim SC. Dermatological Manifestations in Pediatric Patients with Inflammatory Bowel Diseases on Anti-TNF Therapy. Inflamm Bowel Dis. 2018 Apr 27;  

                


                  Maltz RM, Keirsey J, Kim SC, Mackos AR, Gharaibeh RZ, Moore CC, Xu J, Bakthavatchalu V, Somogyi A, Bailey MT. Prolonged restraint stressor exposure in outbred CD-1 mice impacts microbiota, colonic inflammation, and short chain fatty acids. PLoS One. 2018; 13: e0196961.

View More Publications

Research

View My Publications Publications

                  Megan McNicol M, Donegan A, Hawa K, Boutzoukas AE, Drobnic B, Oates M, Orraca-Tetteh M, Michel HK, Maltz RM, Dotson JL, Buckingham D, Boyle B, Ardura MI. Improving Hepatitis B Vaccination Rates among At-risk Children and Adolescents with Inflammatory Bowel Disease. Pediatr Qual Saf. 2022 Jul-Aug; 7: e570.

                


                  Kerur B, Fiedler K, Stahl M, Hyams J, Stephens M, Lu Y, Pfefferkorn M, Alkhouri R, Strople J, Kelsen J, Siebold L, Goyal A, Rosh JR, LeLeiko N, Van Limbergen J, Guerrerio AL, Maltz RM, Karam L, Crowley E, Griffiths AM, Heyman MB, Deneau M, Benkov K, Noe J, Moulton D, Pappa H, Galanko J, Snapper S, Muise AM, Kappelman MD, Benchimol EI. Utilization of anti-tumor necrosis factor biologics in Very Early Onset Inflammatory Bowel Disease (VEOIBD): a multicenter retrospective cohort study from North America. J Pediatr Gastroenterol Nutr. 2022 May 27;  

                


                  Davidson N, Rutsky J, Bricker JB, Smith J, Maltz RM, Dotson JL, Michel HK, Boyle B. 6 and 12-Month Outcomes After 90:10 Enteral Nutrition Induction Therapy in Pediatric Crohn's Disease. J Pediatr Gastroenterol Nutr. 2022 May 27;  

                


                  Maltz RM, Marte-Ortiz P, Rajasekera TA, Loman BR, Gur TL, Bailey MT. Stressor-Induced Increases in Circulating, but Not Colonic, Cytokines Are Related to Anxiety-like Behavior and Hippocampal Inflammation in a Murine Colitis Model. Int J Mol Sci. 2022 Feb 11; 23: 

                


                  Hill EB, Chen L, Bailey MT, Singh Khalsa A, Maltz R, Kelleher K, Spees CK, Zhu J, Loman BR. Facilitating a high-quality dietary pattern induces shared microbial responses linking diet quality, blood pressure, and microbial sterol metabolism in caregiver-child dyads. Gut Microbes. 2022 Jan-Dec; 14: 2150502.

                


                  Salman SS, Williams KC, Marte-Ortiz P, Rumpf W, Mashburn-Warren L, Lauber CL, Bailey MT, Maltz RM. Polyethylene Glycol 3350 Changes Stool Consistency and the Microbiome but not Behavior of CD1 Mice. J Pediatr Gastroenterol Nutr. 2021 Oct 1; 73: 499-506.

                


                  Michel HK, Boyle B, David J, Donegan A, Drobnic B, Kren C, Maltz RM, McKillop HN, McNicol M, Oates M, Dotson JL. The Pediatric Inflammatory Bowel Disease Medical Home: A Proposed Model. Inflamm Bowel Dis. 2021 Sep 25;  

                


                  Morris GA, McNicol M, Boyle B, Donegan A, Dotson J, Michel HK, Maltz RM. Increasing Biosimilar Utilization at a Pediatric Inflammatory Bowel Disease Center and Associated Cost Savings: Show Me the Money. Inflamm Bowel Dis. 2021 May 25;  

                


                  Pearlstein H, Bricker J, Michel HK, Afzali A, Donegan AM, Maltz RM, Boyle BM, Dotson JL. Predicting Suboptimal Transitions in Adolescents With Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr. 2021 Apr 1; 72: 563-568.

                


                  Kerur B, Benchimol EI, Fiedler K, Stahl M, Hyams J, Stephens M, Lu Y, Pfefferkorn M, Alkhouri R, Strople J, Kelsen J, Siebold L, Goyal A, Rosh JR, LeLeiko N, Van Limbergen J, Guerrerio AL, Maltz R, Karam L, Crowley E, Griffiths A, Heyman MB, Deneau M, Benkov K, Noe J, Mouton D, Pappa H, Galanko JA, Snapper S, Muise AM, Kappelman MD. Natural History of? Very Early Onset Inflammatory Bowel Disease in North America: A Retrospective Cohort Study. Inflamm Bowel Dis. 2020 May 9;  

                


                  Lee R, Maltz RM, Crandall WV, Plogsted SW, Shaikhkhalil AK, Bowden SA, Mezoff EA. Single High-dose Vitamin D3 Supplementation in Pediatric Patients With Inflammatory Bowel Disease and Hypovitaminosis D. J Pediatr Gastroenterol Nutr. 2020 Apr; 70: e77-e80.

                


                  Mackner LM, Hatzakis E, Allen JM, Davies RH, Kim SC, Maltz RM, Bailey MT. Fecal microbiota and metabolites are distinct in a pilot study of pediatric Crohn's disease patients with higher levels of perceived stress. Psychoneuroendocrinology. 2020 Jan; 111: 104469.

                


                  Guido AJ, Crandall W, Homan E, Dotson J, Maltz RM, Donegan A, Drobnic B, Oates M, Boyle B. Improving Post-induction Antitumor Necrosis Factor Therapeutic Drug Monitoring in Pediatric Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr. 2020 Jan; 70: 48-54.

                


                  Gupta SR, Crandall WV, Donegan A, Johnson M, Drobnic B, Oates M, Boyle B, Maltz RM, Dotson JL. A Quality Improvement Approach to External Infliximab Infusions in Pediatric Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr. 2019 Nov; 69: 544-550.

                


                  Maltz RM, Keirsey J, Kim SC, Mackos AR, Gharaibeh RZ, Moore CC, Xu J, Somogyi A, Bailey MT. Social Stress Affects Colonic Inflammation, the Gut Microbiome, and Short-chain Fatty Acid Levels and Receptors. J Pediatr Gastroenterol Nutr. 2019 Apr; 68: 533-540.

                


                  Serpico MR, Maltz R, Crandall W, Bricker J, Dotson JL, Kim SC, Boyle B. Thiopurine Optimization Through Combination With Allopurinol in Children With Inflammatory Bowel Diseases. J Pediatr Gastroenterol Nutr. 2018 Sep; 67: 341-345.

                


                  Shaikhkhalil AK, Boyle B, Smith J, Dotson JL, Donegan A, Kim SC, Maltz RM, Crandall W. Using Quality Improvement to Increase Utilization of Enteral Therapy in Pediatric Crohn Disease: Results and Outcomes. J Pediatr Gastroenterol Nutr. 2018 Jun; 66: 909-914.

                


                  Sridhar S, Maltz RM, Boyle B, Kim SC. Dermatological Manifestations in Pediatric Patients with Inflammatory Bowel Diseases on Anti-TNF Therapy. Inflamm Bowel Dis. 2018 Apr 27;  

                


                  Maltz RM, Keirsey J, Kim SC, Mackos AR, Gharaibeh RZ, Moore CC, Xu J, Bakthavatchalu V, Somogyi A, Bailey MT. Prolonged restraint stressor exposure in outbred CD-1 mice impacts microbiota, colonic inflammation, and short chain fatty acids. PLoS One. 2018; 13: e0196961.

View More Publications

View My Publications Publications

                  Megan McNicol M, Donegan A, Hawa K, Boutzoukas AE, Drobnic B, Oates M, Orraca-Tetteh M, Michel HK, Maltz RM, Dotson JL, Buckingham D, Boyle B, Ardura MI. Improving Hepatitis B Vaccination Rates among At-risk Children and Adolescents with Inflammatory Bowel Disease. Pediatr Qual Saf. 2022 Jul-Aug; 7: e570.

                


                  Kerur B, Fiedler K, Stahl M, Hyams J, Stephens M, Lu Y, Pfefferkorn M, Alkhouri R, Strople J, Kelsen J, Siebold L, Goyal A, Rosh JR, LeLeiko N, Van Limbergen J, Guerrerio AL, Maltz RM, Karam L, Crowley E, Griffiths AM, Heyman MB, Deneau M, Benkov K, Noe J, Moulton D, Pappa H, Galanko J, Snapper S, Muise AM, Kappelman MD, Benchimol EI. Utilization of anti-tumor necrosis factor biologics in Very Early Onset Inflammatory Bowel Disease (VEOIBD): a multicenter retrospective cohort study from North America. J Pediatr Gastroenterol Nutr. 2022 May 27;  

                


                  Davidson N, Rutsky J, Bricker JB, Smith J, Maltz RM, Dotson JL, Michel HK, Boyle B. 6 and 12-Month Outcomes After 90:10 Enteral Nutrition Induction Therapy in Pediatric Crohn's Disease. J Pediatr Gastroenterol Nutr. 2022 May 27;  

                


                  Maltz RM, Marte-Ortiz P, Rajasekera TA, Loman BR, Gur TL, Bailey MT. Stressor-Induced Increases in Circulating, but Not Colonic, Cytokines Are Related to Anxiety-like Behavior and Hippocampal Inflammation in a Murine Colitis Model. Int J Mol Sci. 2022 Feb 11; 23: 

                


                  Hill EB, Chen L, Bailey MT, Singh Khalsa A, Maltz R, Kelleher K, Spees CK, Zhu J, Loman BR. Facilitating a high-quality dietary pattern induces shared microbial responses linking diet quality, blood pressure, and microbial sterol metabolism in caregiver-child dyads. Gut Microbes. 2022 Jan-Dec; 14: 2150502.

                


                  Salman SS, Williams KC, Marte-Ortiz P, Rumpf W, Mashburn-Warren L, Lauber CL, Bailey MT, Maltz RM. Polyethylene Glycol 3350 Changes Stool Consistency and the Microbiome but not Behavior of CD1 Mice. J Pediatr Gastroenterol Nutr. 2021 Oct 1; 73: 499-506.

                


                  Michel HK, Boyle B, David J, Donegan A, Drobnic B, Kren C, Maltz RM, McKillop HN, McNicol M, Oates M, Dotson JL. The Pediatric Inflammatory Bowel Disease Medical Home: A Proposed Model. Inflamm Bowel Dis. 2021 Sep 25;  

                


                  Morris GA, McNicol M, Boyle B, Donegan A, Dotson J, Michel HK, Maltz RM. Increasing Biosimilar Utilization at a Pediatric Inflammatory Bowel Disease Center and Associated Cost Savings: Show Me the Money. Inflamm Bowel Dis. 2021 May 25;  

                


                  Pearlstein H, Bricker J, Michel HK, Afzali A, Donegan AM, Maltz RM, Boyle BM, Dotson JL. Predicting Suboptimal Transitions in Adolescents With Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr. 2021 Apr 1; 72: 563-568.

                


                  Kerur B, Benchimol EI, Fiedler K, Stahl M, Hyams J, Stephens M, Lu Y, Pfefferkorn M, Alkhouri R, Strople J, Kelsen J, Siebold L, Goyal A, Rosh JR, LeLeiko N, Van Limbergen J, Guerrerio AL, Maltz R, Karam L, Crowley E, Griffiths A, Heyman MB, Deneau M, Benkov K, Noe J, Mouton D, Pappa H, Galanko JA, Snapper S, Muise AM, Kappelman MD. Natural History of? Very Early Onset Inflammatory Bowel Disease in North America: A Retrospective Cohort Study. Inflamm Bowel Dis. 2020 May 9;  

                


                  Lee R, Maltz RM, Crandall WV, Plogsted SW, Shaikhkhalil AK, Bowden SA, Mezoff EA. Single High-dose Vitamin D3 Supplementation in Pediatric Patients With Inflammatory Bowel Disease and Hypovitaminosis D. J Pediatr Gastroenterol Nutr. 2020 Apr; 70: e77-e80.

                


                  Mackner LM, Hatzakis E, Allen JM, Davies RH, Kim SC, Maltz RM, Bailey MT. Fecal microbiota and metabolites are distinct in a pilot study of pediatric Crohn's disease patients with higher levels of perceived stress. Psychoneuroendocrinology. 2020 Jan; 111: 104469.

                


                  Guido AJ, Crandall W, Homan E, Dotson J, Maltz RM, Donegan A, Drobnic B, Oates M, Boyle B. Improving Post-induction Antitumor Necrosis Factor Therapeutic Drug Monitoring in Pediatric Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr. 2020 Jan; 70: 48-54.

                


                  Gupta SR, Crandall WV, Donegan A, Johnson M, Drobnic B, Oates M, Boyle B, Maltz RM, Dotson JL. A Quality Improvement Approach to External Infliximab Infusions in Pediatric Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr. 2019 Nov; 69: 544-550.

                


                  Maltz RM, Keirsey J, Kim SC, Mackos AR, Gharaibeh RZ, Moore CC, Xu J, Somogyi A, Bailey MT. Social Stress Affects Colonic Inflammation, the Gut Microbiome, and Short-chain Fatty Acid Levels and Receptors. J Pediatr Gastroenterol Nutr. 2019 Apr; 68: 533-540.

                


                  Serpico MR, Maltz R, Crandall W, Bricker J, Dotson JL, Kim SC, Boyle B. Thiopurine Optimization Through Combination With Allopurinol in Children With Inflammatory Bowel Diseases. J Pediatr Gastroenterol Nutr. 2018 Sep; 67: 341-345.

                


                  Shaikhkhalil AK, Boyle B, Smith J, Dotson JL, Donegan A, Kim SC, Maltz RM, Crandall W. Using Quality Improvement to Increase Utilization of Enteral Therapy in Pediatric Crohn Disease: Results and Outcomes. J Pediatr Gastroenterol Nutr. 2018 Jun; 66: 909-914.

                


                  Sridhar S, Maltz RM, Boyle B, Kim SC. Dermatological Manifestations in Pediatric Patients with Inflammatory Bowel Diseases on Anti-TNF Therapy. Inflamm Bowel Dis. 2018 Apr 27;  

                


                  Maltz RM, Keirsey J, Kim SC, Mackos AR, Gharaibeh RZ, Moore CC, Xu J, Bakthavatchalu V, Somogyi A, Bailey MT. Prolonged restraint stressor exposure in outbred CD-1 mice impacts microbiota, colonic inflammation, and short chain fatty acids. PLoS One. 2018; 13: e0196961.

View More Publications

View My Publications

                  Megan McNicol M, Donegan A, Hawa K, Boutzoukas AE, Drobnic B, Oates M, Orraca-Tetteh M, Michel HK, Maltz RM, Dotson JL, Buckingham D, Boyle B, Ardura MI. Improving Hepatitis B Vaccination Rates among At-risk Children and Adolescents with Inflammatory Bowel Disease. Pediatr Qual Saf. 2022 Jul-Aug; 7: e570.

                


                  Kerur B, Fiedler K, Stahl M, Hyams J, Stephens M, Lu Y, Pfefferkorn M, Alkhouri R, Strople J, Kelsen J, Siebold L, Goyal A, Rosh JR, LeLeiko N, Van Limbergen J, Guerrerio AL, Maltz RM, Karam L, Crowley E, Griffiths AM, Heyman MB, Deneau M, Benkov K, Noe J, Moulton D, Pappa H, Galanko J, Snapper S, Muise AM, Kappelman MD, Benchimol EI. Utilization of anti-tumor necrosis factor biologics in Very Early Onset Inflammatory Bowel Disease (VEOIBD): a multicenter retrospective cohort study from North America. J Pediatr Gastroenterol Nutr. 2022 May 27;  

                


                  Davidson N, Rutsky J, Bricker JB, Smith J, Maltz RM, Dotson JL, Michel HK, Boyle B. 6 and 12-Month Outcomes After 90:10 Enteral Nutrition Induction Therapy in Pediatric Crohn's Disease. J Pediatr Gastroenterol Nutr. 2022 May 27;  

                


                  Maltz RM, Marte-Ortiz P, Rajasekera TA, Loman BR, Gur TL, Bailey MT. Stressor-Induced Increases in Circulating, but Not Colonic, Cytokines Are Related to Anxiety-like Behavior and Hippocampal Inflammation in a Murine Colitis Model. Int J Mol Sci. 2022 Feb 11; 23: 

                


                  Hill EB, Chen L, Bailey MT, Singh Khalsa A, Maltz R, Kelleher K, Spees CK, Zhu J, Loman BR. Facilitating a high-quality dietary pattern induces shared microbial responses linking diet quality, blood pressure, and microbial sterol metabolism in caregiver-child dyads. Gut Microbes. 2022 Jan-Dec; 14: 2150502.

                


                  Salman SS, Williams KC, Marte-Ortiz P, Rumpf W, Mashburn-Warren L, Lauber CL, Bailey MT, Maltz RM. Polyethylene Glycol 3350 Changes Stool Consistency and the Microbiome but not Behavior of CD1 Mice. J Pediatr Gastroenterol Nutr. 2021 Oct 1; 73: 499-506.

                


                  Michel HK, Boyle B, David J, Donegan A, Drobnic B, Kren C, Maltz RM, McKillop HN, McNicol M, Oates M, Dotson JL. The Pediatric Inflammatory Bowel Disease Medical Home: A Proposed Model. Inflamm Bowel Dis. 2021 Sep 25;  

                


                  Morris GA, McNicol M, Boyle B, Donegan A, Dotson J, Michel HK, Maltz RM. Increasing Biosimilar Utilization at a Pediatric Inflammatory Bowel Disease Center and Associated Cost Savings: Show Me the Money. Inflamm Bowel Dis. 2021 May 25;  

                


                  Pearlstein H, Bricker J, Michel HK, Afzali A, Donegan AM, Maltz RM, Boyle BM, Dotson JL. Predicting Suboptimal Transitions in Adolescents With Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr. 2021 Apr 1; 72: 563-568.

                


                  Kerur B, Benchimol EI, Fiedler K, Stahl M, Hyams J, Stephens M, Lu Y, Pfefferkorn M, Alkhouri R, Strople J, Kelsen J, Siebold L, Goyal A, Rosh JR, LeLeiko N, Van Limbergen J, Guerrerio AL, Maltz R, Karam L, Crowley E, Griffiths A, Heyman MB, Deneau M, Benkov K, Noe J, Mouton D, Pappa H, Galanko JA, Snapper S, Muise AM, Kappelman MD. Natural History of? Very Early Onset Inflammatory Bowel Disease in North America: A Retrospective Cohort Study. Inflamm Bowel Dis. 2020 May 9;  

                


                  Lee R, Maltz RM, Crandall WV, Plogsted SW, Shaikhkhalil AK, Bowden SA, Mezoff EA. Single High-dose Vitamin D3 Supplementation in Pediatric Patients With Inflammatory Bowel Disease and Hypovitaminosis D. J Pediatr Gastroenterol Nutr. 2020 Apr; 70: e77-e80.

                


                  Mackner LM, Hatzakis E, Allen JM, Davies RH, Kim SC, Maltz RM, Bailey MT. Fecal microbiota and metabolites are distinct in a pilot study of pediatric Crohn's disease patients with higher levels of perceived stress. Psychoneuroendocrinology. 2020 Jan; 111: 104469.

                


                  Guido AJ, Crandall W, Homan E, Dotson J, Maltz RM, Donegan A, Drobnic B, Oates M, Boyle B. Improving Post-induction Antitumor Necrosis Factor Therapeutic Drug Monitoring in Pediatric Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr. 2020 Jan; 70: 48-54.

                


                  Gupta SR, Crandall WV, Donegan A, Johnson M, Drobnic B, Oates M, Boyle B, Maltz RM, Dotson JL. A Quality Improvement Approach to External Infliximab Infusions in Pediatric Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr. 2019 Nov; 69: 544-550.

                


                  Maltz RM, Keirsey J, Kim SC, Mackos AR, Gharaibeh RZ, Moore CC, Xu J, Somogyi A, Bailey MT. Social Stress Affects Colonic Inflammation, the Gut Microbiome, and Short-chain Fatty Acid Levels and Receptors. J Pediatr Gastroenterol Nutr. 2019 Apr; 68: 533-540.

                


                  Serpico MR, Maltz R, Crandall W, Bricker J, Dotson JL, Kim SC, Boyle B. Thiopurine Optimization Through Combination With Allopurinol in Children With Inflammatory Bowel Diseases. J Pediatr Gastroenterol Nutr. 2018 Sep; 67: 341-345.

                


                  Shaikhkhalil AK, Boyle B, Smith J, Dotson JL, Donegan A, Kim SC, Maltz RM, Crandall W. Using Quality Improvement to Increase Utilization of Enteral Therapy in Pediatric Crohn Disease: Results and Outcomes. J Pediatr Gastroenterol Nutr. 2018 Jun; 66: 909-914.

                


                  Sridhar S, Maltz RM, Boyle B, Kim SC. Dermatological Manifestations in Pediatric Patients with Inflammatory Bowel Diseases on Anti-TNF Therapy. Inflamm Bowel Dis. 2018 Apr 27;  

                


                  Maltz RM, Keirsey J, Kim SC, Mackos AR, Gharaibeh RZ, Moore CC, Xu J, Bakthavatchalu V, Somogyi A, Bailey MT. Prolonged restraint stressor exposure in outbred CD-1 mice impacts microbiota, colonic inflammation, and short chain fatty acids. PLoS One. 2018; 13: e0196961.

View More Publications

• Megan McNicol M, Donegan A, Hawa K, Boutzoukas AE, Drobnic B, Oates M, Orraca-Tetteh M, Michel HK, Maltz RM, Dotson JL, Buckingham D, Boyle B, Ardura MI. Improving Hepatitis B Vaccination Rates among At-risk Children and Adolescents with Inflammatory Bowel Disease. Pediatr Qual Saf. 2022 Jul-Aug; 7: e570.
• Kerur B, Fiedler K, Stahl M, Hyams J, Stephens M, Lu Y, Pfefferkorn M, Alkhouri R, Strople J, Kelsen J, Siebold L, Goyal A, Rosh JR, LeLeiko N, Van Limbergen J, Guerrerio AL, Maltz RM, Karam L, Crowley E, Griffiths AM, Heyman MB, Deneau M, Benkov K, Noe J, Moulton D, Pappa H, Galanko J, Snapper S, Muise AM, Kappelman MD, Benchimol EI. Utilization of anti-tumor necrosis factor biologics in Very Early Onset Inflammatory Bowel Disease (VEOIBD): a multicenter retrospective cohort study from North America. J Pediatr Gastroenterol Nutr. 2022 May 27;
• Davidson N, Rutsky J, Bricker JB, Smith J, Maltz RM, Dotson JL, Michel HK, Boyle B. 6 and 12-Month Outcomes After 90:10 Enteral Nutrition Induction Therapy in Pediatric Crohn’s Disease. J Pediatr Gastroenterol Nutr. 2022 May 27;
• Maltz RM, Marte-Ortiz P, Rajasekera TA, Loman BR, Gur TL, Bailey MT. Stressor-Induced Increases in Circulating, but Not Colonic, Cytokines Are Related to Anxiety-like Behavior and Hippocampal Inflammation in a Murine Colitis Model. Int J Mol Sci. 2022 Feb 11; 23:
• Hill EB, Chen L, Bailey MT, Singh Khalsa A, Maltz R, Kelleher K, Spees CK, Zhu J, Loman BR. Facilitating a high-quality dietary pattern induces shared microbial responses linking diet quality, blood pressure, and microbial sterol metabolism in caregiver-child dyads. Gut Microbes. 2022 Jan-Dec; 14: 2150502.
• Salman SS, Williams KC, Marte-Ortiz P, Rumpf W, Mashburn-Warren L, Lauber CL, Bailey MT, Maltz RM. Polyethylene Glycol 3350 Changes Stool Consistency and the Microbiome but not Behavior of CD1 Mice. J Pediatr Gastroenterol Nutr. 2021 Oct 1; 73: 499-506.
• Michel HK, Boyle B, David J, Donegan A, Drobnic B, Kren C, Maltz RM, McKillop HN, McNicol M, Oates M, Dotson JL. The Pediatric Inflammatory Bowel Disease Medical Home: A Proposed Model. Inflamm Bowel Dis. 2021 Sep 25;
• Morris GA, McNicol M, Boyle B, Donegan A, Dotson J, Michel HK, Maltz RM. Increasing Biosimilar Utilization at a Pediatric Inflammatory Bowel Disease Center and Associated Cost Savings: Show Me the Money. Inflamm Bowel Dis. 2021 May 25;
• Pearlstein H, Bricker J, Michel HK, Afzali A, Donegan AM, Maltz RM, Boyle BM, Dotson JL. Predicting Suboptimal Transitions in Adolescents With Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr. 2021 Apr 1; 72: 563-568.
• Kerur B, Benchimol EI, Fiedler K, Stahl M, Hyams J, Stephens M, Lu Y, Pfefferkorn M, Alkhouri R, Strople J, Kelsen J, Siebold L, Goyal A, Rosh JR, LeLeiko N, Van Limbergen J, Guerrerio AL, Maltz R, Karam L, Crowley E, Griffiths A, Heyman MB, Deneau M, Benkov K, Noe J, Mouton D, Pappa H, Galanko JA, Snapper S, Muise AM, Kappelman MD. Natural History of? Very Early Onset Inflammatory Bowel Disease in North America: A Retrospective Cohort Study. Inflamm Bowel Dis. 2020 May 9;
• Lee R, Maltz RM, Crandall WV, Plogsted SW, Shaikhkhalil AK, Bowden SA, Mezoff EA. Single High-dose Vitamin D3 Supplementation in Pediatric Patients With Inflammatory Bowel Disease and Hypovitaminosis D. J Pediatr Gastroenterol Nutr. 2020 Apr; 70: e77-e80.
• Mackner LM, Hatzakis E, Allen JM, Davies RH, Kim SC, Maltz RM, Bailey MT. Fecal microbiota and metabolites are distinct in a pilot study of pediatric Crohn’s disease patients with higher levels of perceived stress. Psychoneuroendocrinology. 2020 Jan; 111: 104469.
• Guido AJ, Crandall W, Homan E, Dotson J, Maltz RM, Donegan A, Drobnic B, Oates M, Boyle B. Improving Post-induction Antitumor Necrosis Factor Therapeutic Drug Monitoring in Pediatric Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr. 2020 Jan; 70: 48-54.
• Gupta SR, Crandall WV, Donegan A, Johnson M, Drobnic B, Oates M, Boyle B, Maltz RM, Dotson JL. A Quality Improvement Approach to External Infliximab Infusions in Pediatric Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr. 2019 Nov; 69: 544-550.
• Maltz RM, Keirsey J, Kim SC, Mackos AR, Gharaibeh RZ, Moore CC, Xu J, Somogyi A, Bailey MT. Social Stress Affects Colonic Inflammation, the Gut Microbiome, and Short-chain Fatty Acid Levels and Receptors. J Pediatr Gastroenterol Nutr. 2019 Apr; 68: 533-540.
• Serpico MR, Maltz R, Crandall W, Bricker J, Dotson JL, Kim SC, Boyle B. Thiopurine Optimization Through Combination With Allopurinol in Children With Inflammatory Bowel Diseases. J Pediatr Gastroenterol Nutr. 2018 Sep; 67: 341-345.
• Shaikhkhalil AK, Boyle B, Smith J, Dotson JL, Donegan A, Kim SC, Maltz RM, Crandall W. Using Quality Improvement to Increase Utilization of Enteral Therapy in Pediatric Crohn Disease: Results and Outcomes. J Pediatr Gastroenterol Nutr. 2018 Jun; 66: 909-914.
• Sridhar S, Maltz RM, Boyle B, Kim SC. Dermatological Manifestations in Pediatric Patients with Inflammatory Bowel Diseases on Anti-TNF Therapy. Inflamm Bowel Dis. 2018 Apr 27;
• Maltz RM, Keirsey J, Kim SC, Mackos AR, Gharaibeh RZ, Moore CC, Xu J, Bakthavatchalu V, Somogyi A, Bailey MT. Prolonged restraint stressor exposure in outbred CD-1 mice impacts microbiota, colonic inflammation, and short chain fatty acids. PLoS One. 2018; 13: e0196961.

Education

Date of Appointment at Nationwide Children’s Hospital: 09/26/2014

Board Certifications

Pediatric Gastroenterology

Fellowship

Nationwide Children’s Hospital

Date Completed: 06/30/2016

Residency

Winthrop University Hospital

Date Completed: 06/30/2013

Medical School

St. Georges University

Date Completed: 04/09/2010

Education

Date of Appointment at Nationwide Children’s Hospital: 09/26/2014

Board Certifications

Pediatric Gastroenterology

Fellowship

Nationwide Children’s Hospital

Date Completed: 06/30/2016

Residency

Winthrop University Hospital

Date Completed: 06/30/2013

Medical School

St. Georges University

Date Completed: 04/09/2010

Education

Date of Appointment at Nationwide Children’s Hospital: 09/26/2014

Board Certifications

Pediatric Gastroenterology

Fellowship

Nationwide Children’s Hospital

Date Completed: 06/30/2016

Residency

Winthrop University Hospital

Date Completed: 06/30/2013

Medical School

St. Georges University

Date Completed: 04/09/2010

Date of Appointment at Nationwide Children’s Hospital: 09/26/2014

Board Certifications

Pediatric Gastroenterology

Fellowship

Nationwide Children’s Hospital

Date Completed: 06/30/2016

Residency

Winthrop University Hospital

Date Completed: 06/30/2013

Medical School

St. Georges University

Date Completed: 04/09/2010

Date of Appointment at Nationwide Children’s Hospital: 09/26/2014

Board Certifications

Pediatric Gastroenterology

Fellowship

Nationwide Children’s Hospital

Date Completed: 06/30/2016

Residency

Winthrop University Hospital

Date Completed: 06/30/2013

Medical School

St. Georges University

Date Completed: 04/09/2010

• Pediatric Gastroenterology

Contact Information

Pediatrics

Call us at: (614) 722-3450

Fax us at: (614) 722-3454

Email Ross M Maltz

                    Gastroenterology & Hepatology & Nutrition700 Children's DrColumbus, OH 43205 (map)

Contact Information

Pediatrics

Call us at: (614) 722-3450

Fax us at: (614) 722-3454

Email Ross M Maltz

                    Gastroenterology & Hepatology & Nutrition700 Children's DrColumbus, OH 43205 (map)

Contact Information

Pediatrics

Call us at: (614) 722-3450

Fax us at: (614) 722-3454

Email Ross M Maltz

                    Gastroenterology & Hepatology & Nutrition700 Children's DrColumbus, OH 43205 (map)

Pediatrics

Call us at: (614) 722-3450

Fax us at: (614) 722-3454

Email Ross M Maltz

                    Gastroenterology & Hepatology & Nutrition700 Children's DrColumbus, OH 43205 (map)

Call us at: (614) 722-3450

Fax us at: (614) 722-3454

Email Ross M Maltz

                    Gastroenterology & Hepatology & Nutrition700 Children's DrColumbus, OH 43205 (map)

Call us at: (614) 722-3450

Fax us at: (614) 722-3454

Email Ross M Maltz

                    Gastroenterology & Hepatology & Nutrition700 Children's DrColumbus, OH 43205 (map)

• Call us at:
• (614) 722-3450
• Fax us at:
• (614) 722-3454
• Email Ross M Maltz
• Gastroenterology & Hepatology & Nutrition700 Children’s DrColumbus, OH 43205 (map)